EXHIBIT 99.1
Sharps Compliance Reports Fourth Quarter Fiscal 2013 Revenue up 16%, Finishes Year With $21.5 Million in Revenue
- Fourth quarter revenue growth driven by $0.3 million, or 115%, increase in Pharmaceutical market and $0.3 million, or 33%, increase in Professional market
- Professional market revenue grew 28% in fiscal 2013; Assisted Living market was up 21%
- Balance sheet remains solid with cash of $15.5 million, working capital of $16.6 million
HOUSTON, Aug. 14, 2013 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq:SMED) ("Sharps" or the "Company"), a leading full-service provider of solutions for the cost-effective management of medical waste, used healthcare materials and unused dispensed medications, today reported financial results for the fourth quarter and fiscal year 2013 ended June 30, 2013.
Revenue in the fourth quarter of fiscal 2013 was $5.3 million, up $0.7 million, or 15.6%, over revenue in the fiscal 2012 fourth quarter of $4.5 million.
Customer billings, the Company's measure for performance and progress of the business, increased $0.6 million, or 13.6%, to $5.1 million compared with the prior-year period, driven by solid growth in billings to the Pharmaceutical and Professional markets. These were offset by lower billings to the Retail market which were softer due to the timing of orders related to the flu shot season. On a sequential basis, customer billings decreased $0.2 million, or 3.7%, compared with $5.3 million in the trailing third quarter. The trailing fiscal 2013 third quarter benefitted from carryover orders associated with the 2012 flu shot season and advance orders for the 2013 flu shot season through the Retail market. (See Reconciliation of Customer Billings to Revenue in the supplemental table included at the end of this release.)
David P. Tusa, President and CEO of Sharps Compliance, commented, "We are continuing to realize results from our strategic initiatives to position ourselves as a preferred provider of comprehensive medical waste management services throughout North America. Our inside and online sales channel continues to drive growth primarily in the Professional market. Additionally, collaborative efforts under our marketing alliance with Daniels Sharpsmart are starting to bear fruit in many of our key markets. More importantly, the quality of our pipeline continues to improve as we create awareness of an alternative in the market place and of our cost effective medical waste solutions."
Focused sales and marketing initiatives drive revenue
Professional market billings grew $0.3 million, or 32.6%, to $1.0 million in the fourth quarter of fiscal 2013. The growth in this market was a direct result of the Company's targeted telemarketing initiatives and promotional activities to educate doctors, dentists and veterinarians of the significant cost advantage and convenience of the Company's Sharps® Recovery System when compared with the traditional pick-up service for the small quantity generator sector. The Company's inside and online sales channel, which is focused primarily on the Professional market, realized a 46.6% increase in billings to $0.9 million in the fiscal 2013 fourth quarter from $0.6 million in the prior-year period.
Fourth quarter Pharmaceutical market billings more than doubled, increasing by $0.3 million, or 115.0%, to $0.6 million. Billings to this market tend to be program related and, therefore, can be highly variable from quarter to quarter until programs mature.
Fourth quarter Assisted Living billings were $0.4 million, up 12.4% over the prior-year period, while Home Health Care billings were flat at $1.9 million compared with the prior-year period.
Retail market billings decreased $0.1 million, or 16.3%, to $0.7 million, compared with the prior-year period. The year-over-year decrease was primarily due to the timing of orders for the traditional flu shot season. Billings to this market were down 60% over the trailing third quarter, which benefitted from carryover orders from the 2012 flu shot season and advance orders for the 2013 flu shot season.
Steady operating performance
Gross margin was 30.1% in the fourth quarter of fiscal 2013 compared with gross margin of 23.1% in the fiscal 2012 fourth quarter. The prior-year margin was negatively impacted by $0.3 million, or 655 basis points, associated with last year's accrued loss for lease-related liabilities for the Company's Atlanta facility resulting from a U.S. Government contract termination.
Selling, general and administrative (SG&A) expense was $2.2 million in the fourth quarter of fiscal year 2013, essentially flat when compared with the fourth quarter of fiscal 2012. The Company expects to maintain a quarterly level of about $2.2 million to $2.4 million in SG&A expense over the next several quarters.
For the fourth quarter of fiscal 2013, the Company had an operating loss of $0.7 million compared with an operating loss of $1.2 million in the same period of the prior year.
Earnings before interest, taxes, depreciation, and amortization, or EBITDA, was a $0.4 million loss for the fourth quarter of fiscal 2013 compared with an EBITDA loss of $1.0 million in the same period of the prior fiscal year. Sharps believes that when used in conjunction with GAAP measures, EBITDA, which is a non-GAAP measure, provides additional information related to its operating performance. (See Reconciliation of Net Loss to EBITDA in the supplemental table included at the end of this release.)
Net loss for the fiscal 2013 fourth quarter was $0.7 million, or $0.05 per diluted share, compared with a net loss of $2.8 million, or $0.18 per diluted share, for the corresponding prior-year period. The current and prior-year periods were negatively impacted by a deferred tax valuation allowance of $0.25 million, or $0.02 per diluted share and $2.0 million, or $0.13 per diluted share, respectively.
Fiscal 2013 review
For the year ended June 30, 2013, revenue was $21.5 million compared with $21.8 million during the prior-year period, which included $1.7 million associated with the maintenance portion of a U.S. government contract. The contract was terminated effective January 31, 2012. Excluding that impact, core customer billings increased 5.9%, or $1.2 million, to $21.3 million during fiscal 2013. Professional billings increased 28.0% to $3.9 million compared with $3.0 million in fiscal 2012. Assisted Living billings increased 20.6% to $1.6 million compared with $1.3 million in the prior-year period. Pharmaceutical billings increased 13.3% to $2.4 million compared with $2.1 million in the prior-year period. Core government billings increased 74.7%, or $0.3 million, to $0.7 million driven by a $0.2 million stocking order placed by the U.S. Department of Defense.
Retail billings were down $0.2 million to $5.0 million compared with fiscal 2012, as a result of timing of customer orders and a new program launch in the prior-year period of the TakeAway Environmental Return System™ solutions. This was somewhat offset by higher sales of the Complete Needle Collection & Disposal System™ in the current fiscal year. Flu shot related orders were down $0.2 million to $3.6 million for the current year.
For fiscal 2013, gross margin was 29.5% compared with 30.0% in the prior fiscal year as operating leverage was impacted by the overhead absorption associated with the termination of the U.S. Government maintenance contract. SG&A expense for fiscal 2013 was comparable to the previous year at $8.6 million.
Operating loss for the year ended June 30, 2013 and 2012 was $2.7 million and $2.5 million, respectively.
EBITDA loss for fiscal 2013 was $1.6 million compared with EBITDA loss of $1.4 million in fiscal 2012. (See Reconciliation of Net Loss to EBITDA in the supplemental table included at the end of this release.)
Net loss was $2.7 million, or $0.18 per diluted share, for the year ended June 30, 2013, compared with a net loss of $3.6 million, or $0.24 per diluted share, for the year ended June 30, 2012. The current and prior-year periods were negatively impacted by a deferred tax valuation allowance of $0.9 million, or $0.06 per diluted share and $2.0 million, or $0.13 per diluted share, respectively.
Financial flexibility and a strong balance sheet
Cash and cash equivalents were $15.5 million at June 30, 2013 compared with $17.5 million at June 30, 2012. Working capital was $16.6 million at June 30, 2013 compared with $18.6 million at the end of fiscal year 2012. At June 30, 2013, stockholders' equity and total assets were $21.1 million and $25.5 million, respectively, compared with $23.2 million and $27.6 million, respectively, at June 30, 2012.
In January 2013, the Company's Board of Directors authorized a stock repurchase program for up to $3 million over a two-year period. During the quarter ended June 30, 2013, no shares of the Company's stock were repurchased. During fiscal 2013, 25,360 shares of the Company's stock were repurchased at an average price of $2.93 per share.
Outlook
Mr. Tusa noted, "The small quantity generator market place has been looking for alternatives to the traditional and expensive pick-up service for years. We believe the change in the healthcare environment is driving more healthcare providers to find new ways to increase efficiencies and reduce cost. Our transformation from a mailback company to a full services medical waste management company allows us to better address those needs. Additionally, we believe that changing demographics and an anticipated significant increase in alternative site administration of healthcare will drive demand for cost effective medical waste solutions at a faster pace in the coming years. We expect to capitalize on the investments we have made in sales initiatives and innovative solutions, and believe we are well positioned to educate the market place that we are an alternative provider that is positioned to service their needs for safe and cost effective medical waste management."
Fourth quarter and fiscal year 2013 webcast and conference call
The Company will host a teleconference today beginning at 11:00 a.m. Eastern Time, during which management will review the financial and operating results for the period and discuss Sharps' corporate strategy and outlook. A question-and-answer session will follow.
The Sharps conference call can be accessed by dialling (201) 689-8560. The webcast can be monitored at www.sharpsinc.com. Webcast listeners will have the opportunity to submit questions to the speakers. Select questions will be summarized and addressed during the question-and-answer portion of the call.
A telephonic replay will be available from 2:00 p.m. ET the day of the teleconference until Wednesday, August 28, 2013. To listen to the archived call, dial (858) 384-5517, and enter conference ID number 417136. A transcript will also be posted to Sharps' website, once available.
About Sharps Compliance Corp.
Headquartered in Houston, Texas, Sharps Compliance is a leading full-service provider of comprehensive medical waste management services throughout North America. Its strategy is to capture a large part of the estimated $3.8 billion untapped market for its solutions by targeting the major agencies that are interrelated with this medical waste stream, including pharmaceutical manufacturers, home healthcare providers, retail pharmacies and clinics, the U.S. government and the professional market which is comprised of physicians, dentists and veterinary practices. The Company's flagship product, the Sharps® Recovery System is a comprehensive solution for the containment, transportation, treatment and tracking of medical waste and used healthcare materials. The Company has partnered with Daniels Sharpsmart in a joint marketing alliance to serve the entire U.S. medical waste market, addressing small and large quantity medical waste generators with highly cost-effective and compliant solutions. Its innovative offerings serve the needs of healthcare and physician's facilities, dental groups and veterinarians that have multi-site and multi-size locations.
More information on the Company and its products can be found on its website at: www.sharpsinc.com
Safe harbor statement
The information made available in this news release contains certain forward-looking statements which reflect Sharps Compliance Corp.'s current view of future events and financial performance. Wherever used, the words "estimate," "expect," "plan," "anticipate," "believe," "may" and similar expressions identify forward-looking statements. Any such forward-looking statements are subject to risks and uncertainties and the company's future results of operations could differ materially from historical results or current expectations. Some of these risks include, without limitation, the company's ability to educate its customers, development of public awareness programs to educate the identified consumer, customer preferences, the Company's ability to scale the business and manage its growth, the degree of success the Company has at gaining more large customer contracts, managing regulatory compliance and/or other factors that may be described in the company's annual report on Form 10-K, quarterly reports on Form 10-Q and/or other filings with the Securities and Exchange Commission. Future economic and industry trends that could potentially impact revenues and profitability are difficult to predict. The Company assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results express or implied therein will not be realized.
This release contains certain financial information not derived in accordance with generally accepted accounting principles ("GAAP"), including customer billings information, EBITDA and non-GAAP net income (loss) per share. The Company believes this information is useful to investors and other interested parties. Such information should not be considered as a substitute for any measure derived in accordance with GAAP, and may not be comparable to other similarly titled measures of other companies. Reconciliation of this information to the most comparable GAAP measures is included as an attachment to this release.
FINANCIAL TABLES FOLLOW.
| SHARPS COMPLIANCE CORP. AND SUBSIDIARIES | ||||||
| Condensed Consolidated Statements of Operations | ||||||
| (in thousands, except per share data) | ||||||
| Three-Months Ended | Twelve-Months Ended | |||||
| June 30, | June 30, | |||||
| (Unaudited) | (Unaudited) | |||||
| 2013 | 2012 | % Change | 2013 | 2012 | % Change | |
| Revenue | $ 5,250 | $ 4,541 | 15.6% | $ 21,530 | $ 21,787 | (1.2%) |
| Cost of revenue | 3,671 | 3,491 | 5.2% | 15,183 | 15,246 | (0.4%) |
| Gross profit | 1,579 | 1,050 | 50.4% | 6,347 | 6,541 | (3.0%) |
| Gross margin | 30.1% | 23.1% | 29.5% | 30.0% | ||
| SG&A expense | 2,168 | 2,184 | (0.7%) | 8,619 | 8,609 | 0.1% |
| Depreciation and amortization | 106 | 115 | (7.8%) | 437 | 453 | (3.5%) |
| Operating loss | (695) | (1,249) | (2,709) | (2,521) | ||
| Operating margin | (13.2%) | (27.5%) | (12.6%) | (11.6%) | ||
| Other income (expense) | (10) | 9 | 12 | 23 | ||
| Loss before income taxes | (705) | (1,240) | (2,697) | (2,498) | ||
| Income tax expense (benefit) | (15) | 1,564 | 15 | 1,123 | ||
| Net loss | $ (690) | $ (2,804) | $ (2,712) | $ (3,621) | ||
| Net loss per share | ||||||
| Basic | $ (0.05) | $ (0.18) | $ (0.18) | $ (0.24) | ||
| Diluted | $ (0.05) | $ (0.18) | $ (0.18) | $ (0.24) | ||
| Weighted Average Shares Outstanding | ||||||
| Basic | 15,333 | 15,185 | 15,255 | 15,109 | ||
| Diluted | 15,333 | 15,185 | 15,255 | 15,109 | ||
| SHARPS COMPLIANCE CORP. AND SUBSIDIARIES | ||
| Condensed Consolidated Balance Sheets | ||
| (in thousands) | ||
| June 30, 2013 | June 30, 2012 | |
| (Unaudited) | ||
| ASSETS: | ||
| Current assets: | ||
| Cash and cash equivalents | $ 15,503 | $ 17,498 |
| Restricted cash | 111 | -- |
| Accounts receivable, net | 2,595 | 2,215 |
| Inventory | 1,632 | 2,219 |
| Prepaid and other current assets | 583 | 610 |
| Total current assets | 20,424 | 22,542 |
| Property, plant and equipment, net | 4,440 | 4,632 |
| Intangible assets, net | 668 | 464 |
| Total assets | $ 25,532 | $ 27,638 |
| LIABILITIES AND STOCKHOLDERS' EQUITY: | ||
| Current liabilities: | ||
| Accounts payable | $ 1,085 | $ 752 |
| Accrued liabilities | 1,345 | 1,302 |
| Deferred revenue | 1,351 | 1,881 |
| Total current liabilities | 3,781 | 3,935 |
| Long-term deferred revenue | 579 | 358 |
| Other long-term liabilities | 102 | 165 |
| Total liabilities | 4,462 | 4,458 |
| Stockholders' equity: | ||
| Total stockholders' equity | 21,070 | 23,180 |
| Total liabilities and stockholders' equity | $ 25,532 | $ 27,638 |
| SHARPS COMPLIANCE CORP. AND SUBSIDIARIES | |||||
| Supplemental Customer Billing and Revenue Information | |||||
| (unaudited) | |||||
| (in thousands) | |||||
| Three-Months Ended June 30, | |||||
| 2013 | % Total | 2012 | $ Change | % | |
| BILLINGS BY MARKET: | |||||
| Home Health Care | $ 1,876 | 37.1% | $ 1,871 | $ 5 | 0.3% |
| Retail | 698 | 13.8% | 834 | (136) | (16.3%) |
| Professional | 1,037 | 20.5% | 782 | 255 | 32.6% |
| Pharmaceutical | 602 | 11.9% | 280 | 322 | 115.0% |
| Assisted Living | 416 | 8.2% | 370 | 46 | 12.4% |
| Core Government | 136 | 2.7% | 94 | 42 | 44.7% |
| Other | 294 | 5.8% | 222 | 72 | 32.4% |
| U.S. Government Contract | -- | 0.0% | -- | -- | -- |
| Subtotal | 5,059 | 100.0% | 4,453 | 606 | 13.6% |
| GAAP Adjustment * | 191 | 88 | 103 | 117.0% | |
| Revenue Reported | $ 5,250 | $ 4,541 | $ 709 | 15.6% | |
| Twelve-Months Ended June 30, | |||||
| 2013 | % Total | 2012 | $ Change | % | |
| BILLINGS BY MARKET: | |||||
| Home Health Care | $ 6,721 | 31.6% | $ 6,856 | $ (135) | (2.0%) |
| Retail | 5,041 | 23.7% | 5,259 | (218) | (4.1%) |
| Professional | 3,863 | 18.2% | 3,019 | 844 | 28.0% |
| Pharmaceutical | 2,413 | 11.3% | 2,129 | 284 | 13.3% |
| Assisted Living | 1,576 | 7.4% | 1,307 | 269 | 20.6% |
| Core Government | 732 | 3.4% | 419 | 313 | 74.7% |
| Other | 937 | 4.4% | 1,114 | (177) | (15.9%) |
| U.S. Government Contract | -- | 0.0% | 1,685 | (1,685) | (100.0%) |
| Subtotal | 21,283 | 100.0% | 21,788 | (505) | (2.3%) |
| GAAP Adjustment * | 247 | (1) | 248 | (24,800%) | |
| Revenue Reported | $ 21,530 | $ 21,787 | (257) | (1.2%) | |
| * Represents the net impact of the revenue recognition adjustments to arrive at reported GAAP revenue. | |||||
| Customer billings include all invoiced amounts for products shipped during the period reported. | |||||
| GAAP revenue includes customer billings as well as numerous adjustments necessary to reflect, (i) the deferral of a portion of current period sales and (ii) recognition of certain revenue associated with product returned for treatment and destruction. The difference between customer billings and GAAP revenue is reflected in the Company's balance sheet as deferred revenue. | |||||
| SHARPS COMPLIANCE CORP. AND SUBSIDIARIES | |||||
| Supplemental Customer Billing by Channel Information | |||||
| (unaudited) | |||||
| (in thousands) | |||||
| Three-Months Ended June 30, | |||||
| 2013 | % Total | 2012 | $ Change | % Change | |
| BILLINGS BY CHANNEL: | |||||
| Direct Sales | $ 1,705 | 33.7% | $ 1,236 | $ 469 | 37.9% |
| Distributors | 2,429 | 48.0% | 2,586 | (157) | (6.1%) |
| Inside and Online Sales | 925 | 18.3% | 631 | 294 | 46.6% |
| Total Billings By Channel | $ 5,059 | 100.0% | $ 4,453 | $ 606 | 13.6% |
| Twelve-Months Ended June 30, | |||||
| 2013 | % Total | 2012 | $ Change | % Change | |
| BILLINGS BY CHANNEL: | |||||
| Direct Sales | $ 8,139 | 38.3% | $ 8,377 | $ (238) | (2.8%) |
| Distributors | 9,884 | 46.4% | 9,421 | 463 | 4.9% |
| Inside and Online Sales | 3,260 | 15.3% | 2,305 | 955 | 41.4% |
| U.S. Government Contract | -- | 0.0% | 1,685 | (1,685) | (100.0%) |
| Total Billings By Channel | $ 21,283 | 100.0% | $ 21,788 | $ (505) | (2.3%) |
| SHARPS COMPLIANCE CORP. AND SUBSIDIARIES | ||||
| Supplemental Table to Reconcile Net Loss to EBITDA | ||||
| (unaudited) | ||||
| (in thousands) | ||||
| Three-Months Ended | Twelve-Months Ended | |||
| June 30, | June 30, | |||
| 2013 | 2012 | 2013 | 2012 | |
| Net loss | $ (690) | $ (2,804) | $ (2,712) | $ (3,621) |
| Income tax expense (benefit) | (15) | 1,564 | 15 | 1,123 |
| Interest income | (6) | (9) | (28) | (37) |
| Depreciation and amortization | 276 | 287 | 1,103 | 1,117 |
| EBITDA | $ (435) | $ (962) | $ (1,622) | $ (1,418) |
| The Company defines earnings before interest, taxes, depreciation and amortization ("EBITDA") as net income (loss), plus income tax (benefit) expense, interest (income) expense, and depreciation and amortization. Other companies may define EBITDA differently. EBITDA is presented because it is a financial measure that is frequently requested by third parties. However, EBITDA is not considered under generally accepted accounting principles as a primary measure of an entity's financial results, and accordingly, EBITDA should not be considered an alternative to operating income (loss), net income (loss), or cash flows as determined under generally accepted accounting principles and as reported by the Company. | ||||
| SHARPS COMPLIANCE CORP. AND SUBSIDIARIES | ||||
| Supplemental Reconciliation of GAAP to Non-GAAP Net Loss per Share * | ||||
| (unaudited) | ||||
| (in thousands, except per share data) | ||||
| Three-Months Ended | Twelve-Months Ended | |||
| June 30, | June 30, | |||
| 2013 | 2012 | 2013 | 2012 | |
| Net loss | $ (690) | $ (2,804) | $ (2,712) | $ (3,621) |
| Diluted net loss per share | $ (0.05) | $ (0.18) | $ (0.18) | $ (0.24) |
| Adjustments, net of tax: | ||||
| Accrued loss on sublease | -- | 197 | 102 | 197 |
| Severance costs | -- | -- | 121 | -- |
| Adjustments | $ -- | $ 197 | $ 223 | $ 197 |
| Deferred Tax Valuation Allowance | $ 253 | $ 1,961 | $ 923 | $ 1,961 |
| Adjusted Net Loss | $ (437) | $ (646) | $ (1,566) | $ (1,463) |
| Adjusted diluted net income (loss) per share* | $ (0.03) | $ (0.04) | $ (0.10) | $ (0.10) |
| * In accordance with U.S. generally accepted accounting principles (GAAP), reported net income (loss) per share includes the after-tax impact of the items identified in this table. The Company believes this information is useful to investors and other interested parties. Such information would not be considered as a substitute for any measure derived in accordance with GAAP, and may not be comparable to other similarly titled measures of other companies. | ||||
CONTACT: Diana P. Diaz
Sharps Compliance Corp.
Vice President and Chief Financial Officer
Phone: (713) 660-3547
Email: ddiaz@sharpsinc.com
- OR -
Deborah K. Pawlowski
Kei Advisors LLC
Investor Relations
Phone: (716) 843-3908
Email: dpawlowski@keiadvisors.com